Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 May 2025 | Story André Damons | Photo Supplied
Prof Wynand Goosen
Prof Wynand Goosen, Professor and Lead for One Health in the Department of Microbiology and Biochemistry at the University of the Free State was nominated in the TW Kambule-NSTF Award: Researcher category of the 2024/25 NSTF-South32 Awards.

Being nominated for a ‘Science Oscar’ is exciting and validates nominees’ efforts, particularly in a field as challenging and essential as infectious diseases, for which they are recognised at the highest level. 

This is according to Prof Wynand Goosen, Professor and Lead for One Health in the Department of Microbiology and Biochemistry at the University of the Free State (UFS). He was nominated in the TW Kambule-NSTF Award: Researcher category of the 2024/25 NSTF-South32 Awards for his landmark discovery of Mycobacterium bovis infection in humans in South Africa – the first confirmed cases in the country. 

Prof Goosen, who previously won the NSTF-South32 Emerging Researcher Award, says the nomination is a powerful affirmation of the impact that focused, interdisciplinary research can have. It reflects not only his personal commitment but also the dedication of a talented and hard-working team. “I am honoured and humbled to be nominated. It is also a testament to the support and vision of UFS, particularly as we position ourselves as leaders in One Health research in South Africa,” he says. 

 

Focus of research 

He was nominated by Prof Vasu Reddy, UFS Deputy Vice-Chancellor: Research and Internationalisation, and Prof Paul Oberholster, Dean for the Faculty of Natural and Agricultural Sciences (NAS) at the UFS, and Prof Nico Gey van Pittius and Prof Elmi Muller from Stellenbosch University (US). The NSTF Awards, known as the ‘Science Oscars’of SA, honour, reward, celebrate, profile and promote outstanding contributions to science, engineering and technology (SET) and innovation in South Africa.

“The nomination,” Prof Goosen continues, “recognises our work in the field of zoonotic tuberculosis (TB) and other emerging infectious diseases at the human-animal-environment interface. Our research focuses on the molecular detection and characterisation of pathogenic mycobacteria in wildlife, livestock, and human populations, with the aim of informing better surveillance, diagnostics, and control strategies — particularly in high-risk ecosystems. This includes novel applications in wildlife TB surveillance and understanding the transmission dynamics between animals and people.”

 

Establishing a Kovsie One Health Research Unit

This research is critically important as South Africa continues to face a high burden of tuberculosis, including zoonotic TB, which often goes under-detected in rural and wildlife-rich areas. Understanding how these pathogens circulate between humans, animals, and the environment, explains Prof Goosen, is essential for effective disease control and to mitigate future pandemics. This work directly supports national health priorities, informs policy, and contributes to global strategies for One Health.

Prof Goosen and the team are in the process of laying the groundwork for the establishment of a Kovsie One Health Research Unit, which will serve as a collaborative platform for research spanning human, animal, and environmental health. One of their key projects involves expanding TB and AMR surveillance in wildlife-livestock-human interfaces, using cutting-edge diagnostics and genomic tools. They are also initiating partnerships with industry and international institutions to address emerging zoonoses and environmental pathogens in a transdisciplinary manner.

News Archive

Bloemfontein’s Visser brothers to wow hometown fans
2013-03-27

 

From left: Vincent Visser, Gareth Cliff and Vicus Visser
Photo: Supplied
27 March 2013

South Africa’s YouTube singing sensation, Vicus Visser, will wow Bloemfonteiners on 18 April 2013 with a musical performance at the University of the Free State.

He and his talented brother Vincent will perform at the Wynand Mouton Theatre giving their hometown fans a taste of their recent performances in the United States. Vicus, who has been dubbed Bloemfontein’s Justin Bieber, performed overseas for the first time in February this year when he and his brother performed at events for Black History Month in Washington DC and New York. One of their performances was at the Kennedy Centre in Washington DC where they paid tribute to Nelson Mandela and Martin Luther King.

Vicus rose to fame in 2010 when a music clip of him as a ten year old boy, singing “These Arms” by All for One, appeared on the internet. After a massive seven-year search on social media channels by local and international record companies, he was tracked down to Heidedal in Bloemfontein. Vicus and Vincent moved to Johannesburg in 2012 where they were managed and mentored by Gareth Cliff, top radio presenter and judge on Idols South Africa.

Gareth will join the Visser brothers in Bloemfontein on 18 April and will be master of ceremonies at the concert titled Singing the Dream for South Africa - The Kennedy Centre Performance. As with their performance in the United States, the brothers will treat the hometown crowd to a selection of songs in English, Zulu, Sesotho and Afrikaans.

Vicus, Vincent and Gareth will also make special appearances at the two graduation ceremonies hosted at 09:30 and 14:30 on 18 April 2013. Gareth will be guest speaker and the two brothers will give a short performance. They will also have a meet and greet session with students at the Thakaneng Bridge at 11:45.

Tickets for the Singing the Dream for South Africa - The Kennedy Centre Performance cost R 20 and are available at Room 5, Thakaneng Bridge. The show starts at 19:30.

For more information contact Nicoleen Snyman at snymann@ufs.ac.za or 051 401 9598 / 051 401 9102.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept